Epidemiology

You have full text access to this OnlineOpen article

Validation of quality indicators for radical prostatectomy

  1. Ellen O.M. Chan1,
  2. Patti A. Groome1,†,*,
  3. D. Robert Siemens2

Article first published online: 18 AUG 2008

DOI: 10.1002/ijc.23782

Issue

International Journal of Cancer

International Journal of Cancer

Volume 123, Issue 11, pages 2651–2657, 1 December 2008

Additional Information

How to Cite

Chan, E. O.M., Groome, P. A. and Siemens, D. R. (2008), Validation of quality indicators for radical prostatectomy. Int. J. Cancer, 123: 2651–2657. doi: 10.1002/ijc.23782

Author Information

  1. 1

    Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada

  2. 2

    Department of Urology, Queen's University, Kingston, Ontario, Canada

  1. †

    Fax: +613-533-6794.

*Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, 10 Stuart St., 2nd Level, Kingston, Ontario, Canada K7L 3N6

Publication History

  1. Issue published online: 24 SEP 2008
  2. Article first published online: 18 AUG 2008
  3. Manuscript Accepted: 3 JUN 2008
  4. Manuscript Received: 18 DEC 2007

Funded by

  • Ontario Graduate Scholarship
  • Empire Life Fellowship
  • National Cancer Institute of Canada

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (102K)

References

  • 1
    Canadian Cancer Society/National Cancer Institute of Canada. Canadian Cancer Statistics 2006. Toronto: Canadian Cancer Society/National Cancer Institute of Canada, 2006.
  • 2
    WalshPC,RetikAB,VaughanE,DarracottE,Jr,WeinAJ, eds. Campbell's urology,7th edn., vol. 1. Philadelphia: W.B. Saunders Company, 1998.
  • 3
    Goldenberg SL,Ramsey EW,Jewett MA. Prostate cancer: 6. surgical treatment of localized disease. CMAJ 1998; 159: 1265–71.
  • 4
    US National Institutes of Health. Prostate cancer treatment: health professional edition. Bethesda, MD: National Cancer Institute, US National Institutes of Health [updated 2007 Mar 14, cited 2007 Jun 6]. Available from: http://www.cancer.gov/cancertopics/pdq/treatment/prostate/healthprofessional.
  • 5
    Linton KD,Hamdy FC. Early diagnosis and surgical management of prostate cancer. Cancer Treat Rev 2003; 29: 151–60.
  • 6
    Nam RK,Jewett MA,Krahn MD. Prostate cancer: 2. natural history. CMAJ 1998; 159: 685–91.
  • 7
    Gagliardi AR,Fleshner N,Langer B,Stern H,Brown AD. Development of prostate cancer quality indicators: a modified Delphi approach. Can J Urol 2005; 12: 2808–15.
  • 8
    Chong CC,Austen L,Kneebone A,Lalak A,Jalaludin B. Patterns of practice in the management of prostate cancer: results from multidisciplinary surveys of clinicians in Australia and New Zealand in 1995 and 2000. BJU Int 2006; 97: 975–80.
    Direct Link:
  • 9
    Morris CR,Snipes KP,Schlag R,Wright WE. Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States). Cancer Causes Control 1999; 10: 503–11.
  • 10
    Roemeling S,Roobol MJ,Postma R,Gosselaar C,van der Kwast TH,Bangma CH,Schroder FH. Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance. Eur Urol 2006; 50: 475–82.
  • 11
    Bauvin E,Soulie M,Menegoz F,Mace-Lesec'h J,Buemi A,Velten M,Villers A,Grosclaude P. Medical and non-medical determinants of prostate cancer management: a population-based study. Eur J Cancer 2003; 39: 2364–71.
  • 12
    Lu-Yao GL,McLerran D,Wasson J,Wennberg JE. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The prostate patient outcomes research team. JAMA 1993; 269: 2633–6.
  • 13
    Iscoe NA,To T,Gort E,Tran M. Cancer surgery in Ontario. Toronto: Institute for Clinical Evaluative Sciences, 1997.
  • 14
    Wilt TJ,Cowper DC,Gammack JK,Going DR,Nugent S,Borowsky SJ. An evaluation of radical prostatectomy at Veteran's Affairs Medical Centers: time trends and geographic variation in utilization and outcomes. Med Care 1999; 37: 1046–56.
  • 15
    Wennberg J,Gittelsohn A. Variations in medical care among small areas. Sci Am 1982; 246: 120–34.
  • 16
    Ellison LM,Trock BJ,Poe NR,Partin AW. The effect of hospital volume on cancer control after radical prostatectomy. J Urol 2005; 173: 2094–8.
  • 17
    Litwin MS,Steinberg M,Malin J,Naitoh J,McGuigan KA,Steinfeld R,Adams J,Brook RH. Prostate cancer patient outcomes and choice of providers: development of an infrastructure for quality assessment. Santa Monica, CA: RAND, 2000.
  • 18
    Spencer BA,Steinberg M,Malin J,Adams J,Litwin MS. Quality- of-care indicators for early-stage prostate cancer. J Clin Oncol 2003; 21: 1928–36.
  • 19
    Miller DC,Montie JE,Wei JT. Measuring the quality of care for localized prostate cancer. J Urol 2005; 174: 425–31.
  • 20
    Cancer Quality Council of Ontario. Strengthening the quality of cancer services in ontario. Toronto: Canadian Healthcare Association Press, 2003.
  • 21
    Miller DC,Litwin MS,Sanda MG,Montie JE,Dunn RL,Resh J,Sandler H,Wei JT. Use of quality indicators to evaluate the care of patients with localized prostate carcinoma. Cancer 2003; 97: 1428–35.
    Direct Link:
  • 22
    Krupski TL,Bergman J,Kwan L,Litwin MS. Quality of prostate carcinoma care in a statewide public assistance program. Cancer 2005; 104: 985–92.
    Direct Link:
  • 23
    Miller DC,Spencer BA,Ritchey J,Stewart AK,Dunn RL,Sandler HM,Wei JT,Litwin MS. Treatment choice and quality of care for men with localized prostate cancer. Med Care 2007; 45: 401–9.
  • 24
    McDowell I,Newell C. Measuring health: a guide to rating scales and questionnaires, 2nd edn. New York: Oxford University Press, 1996.
  • 25
    KaneRL, ed. Understanding health care outcomes research. Gaithersburg, MD: Aspen Publishers, 1997.
  • 26
    Begg CB,Riedel ER,Bach PB,Kattan MW,Schrag D,Warren JL,Scardino PT. Variations in morbidity after radical prostatectomy. N Engl J Med 2002; 346: 1138–44.
  • 27
    Nuttall M,van der MJ,Phillips N,Sharpin C,Gillatt D,McIntosh G,Emberton M. A systematic review and critique of the literature relating hospital or surgeon volume to health outcomes for 3 urological cancer procedures. J Urol 2004; 172: t-52.
  • 28
    Ellison LM,Heaney JA,Birkmeyer JD. The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol 2000; 163: 867–9.
  • 29
    Hu JC,Gold KF,Pashos CL,Mehta SS,Litwin MS. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol 2003; 21: 401–5.
  • 30
    Siemens DR,Schulze KM,Mackillop WJ,Brundage MD,Groome PA. A population-based study of the waiting times for prostatectomy in Ontario. Can J Urol 2005; 12: 2568–74.
  • 31
    Boulos DL,Groome PA,Brundage MD,Siemens DR,Mackillop WJ,Heaton JP,Schulze KM,Rohland SL. Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent. Cancer 2006; 106: 1804–14.
    Direct Link:
  • 32
    Commission on Professional and Hospital Activities. The International classification of diseases; 9th revision, clinical modification; ICD-9-CM. Ann Arbor, MI, 1978.
  • 33
    MedQuest Software [computer program]. Version 32. Baltimore: US Centers for Medicare & Medicaid Services, 1998.
  • 34
    Statistics Canada HD. Canadian classification of diagnostic, therapeutic, and surgical procedures. Ottawa: Minister of Supply and Services Canada, 1986.
  • 35
    Eastham JA,Kattan MW,Rogers E,Goad JR,Ohori M,Boone TB,Scardino PT. Risk factors for urinary incontinence after radical prostatectomy. J Urol 1996; 156: 1707–13.
  • 36
    Alibhai SM,Leach M,Tomlinson G,Krahn MD,Fleshner N,Holowaty E,Naglie G. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. J Natl Cancer Inst 2005; 97: 1525–32.
  • 37
    US National Institutes of Health. Prostate cancer treatment: health professional edition. Bethesda, MD: National Cancer Institute, US National Institutes of Health [updated 2006 May 25, cited 2006 Jun 5]. Available from: http://www.cancer.gov/cancertopics/pdq/treatment/prostate/healthprofessional/allpages.
  • 38
    KantoffPW,CarrollPR,D'AmicoAV, eds. Prostate Cancer: Principles & Practice,1st edn. Philadelphia: Lippincott, 2002.
  • 39
    Linn BS,Linn MW,Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968; 16: 622–6.
  • 40
    Miller MD,Paradis CF,Houck PR,Mazumdar S,Stack JA,Rifai AH,Mulsant B,Reynolds CF. Rating chronic medical illness burden in geropsychiatric practice and research: application of cumulative illness rating scale. Psychiatry Res 1992; 41: 237–48.
  • 41
    Ansari MZ,Ackland MJ,Jolley DJ,Carson N,McDonald IG. Inter-hospital comparison of mortality rates. Int J Qual Health Care 1999; 11: 29–35.
  • 42
    Ansari MZ,Costello AJ,Jolley DJ,Ackland MJ,Carson N,McDonald IG. Adverse events after prostatectomy in Victorian public hospitals. Aust N Z J Surg 1998; 68: 830–6.
  • 43
    Fleshner N. Defining high-risk prostate cancer: current status. Can J Urol 2005; 12 ( Suppl 1): 14–7.
  • 44
    D'Amico AV,Whittington R,Malkowicz SB,Fondurulia J,Chen MH,Kaplan I,Beard CJ,Tomaszewski JE,Renshaw AA,Wein A,Coleman CN. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 1999; 17: 168–72.
  • 45
    D'Amico AV,Whittington R,Malkowicz SB,Wu YH,Chen M,Art M,Tomaszewski JE,Wein A. Combination of the preoperative PSA level, biopsy gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer. Urology 2000; 55: 572–7.
  • 46
    D'Amico AV,Moul J,Carroll PR,Sun L,Lubeck D,Chen MH. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003; 21: 2163–72.
  • 47
    Doherty AP,Bower M,Smith GL,Miano R,Mannion EM,Mitchell H,Christmas TJ. Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival. Br J Cancer 2000; 83: 1432–6.
  • 48
    SAS (Statitiscal Analysis Software) [computer program]. Version 8.2. Cary, NC: SAS Institute, 2000.
  • 49
    SAS v9 Documentation. Cary, NC: SAS Institute, Inc The FREQ Procedure: Cochran-Armitage Test for Trend [updated 2003, cited 2007 Mar 18]. Available from: http://support.sas.com/91doc/getDoc/procstat.hlp/freq_sect24.htm.
  • 50
    SAS v9 Documentation. Cary, NC: SAS Institute, Inc The NPAR1WAY Procedure: Exact Tests [updated 2003, cited 2007 Mar 18]. Available from: http://support.sas.com/91doc/getDoc/statug.hlp/npar1way_sect19.htm#stat_npar1way_np1exmc1.
  • 51
    Rothman KJ,Greenland S. Modern epidemiology, 2nd edn. Philadelphia: Lippincott-Raven, 1998.
  • 52
    Hu JC,Gold KF,Pashos CL,Mehta SS,Litwin MS. Temporal trends in radical prostatectomy complications from 1991 to 1998. J Urol 2003; 169: 1443–8.
  • 53
    British Columbia Cancer Agency. Cancer management guidelines: prostate. Vancouver, BC: British Columbia Cancer Agency [updated 2006 Jun 30, cited 2007 Jun 6]. Available from: http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Genitourinary/Prostate/default.htm.
  • 54
    Yao SL,Lu-Yao GL. Population-based study of relationships between hospital volume of prostatectomies, patient outcomes, and length of hospital stay. J Natl Cancer Inst 1999; 91: 1950–6.
  • 55
    Bianco FJ,Jr,Riedel ER,Begg CB,Kattan MW,Scardino PT. Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. J Urol 2005; 173: 2099–103.
  • 56
    Joudi FN,Konety BR. The impact of provider volume on outcomes from urological cancer therapy. J Urol 2005; 174: 432–8.
  • 57
    Holowaty EJ,Dale D. The hospital only project. Health Rep 1993; 5: 91–5.
  • 58
    Holowaty EJ,Moravan V,Lee G,Chong N,Dale D. A reabstraction study to estimate the completeness and accuracy of data elements in the Ontario Cancer Registry. Cancer Care Ontario Report 1996.
  • 59
    Canadian Institute for Health Information. Data quality documentation: discharge abstract database 2001-2002. Ottawa; CIHI, 2003.
  • 60
    Alivizatos G,Skolarikos A. Incontinence and erectile dysfunction following radical prostatectomy: a review. Sci World J 2005; 5: 747–58.
  • 61
    Robinson JW,Dufour MS,Fung TS. Erectile functioning of men treated for prostate carcinoma. Cancer 1997; 79: 538–44.
    Direct Link:
  • 62
    Shekarriz B,Upadhyay J,Wood DP. Intraoperative, perioperative, and long-term complications of radical prostatectomy. Urologic Clin North Am 2001; 28: 639–53.
  • 63
    Power and Precision [computer program]. Version 2.1. Englewood, NJ: Biostat, 2001.
  • 64
    Cancer Care Ontario. Cancer Quality Council of Ontario. Cancer Service Quality Index 2007 [Internet]. Toronto: Cancer Care Ontario [updated 2007, cited 2007 Jun 10]. Available from: http://www.cancercare.on.ca/qualityindex2007/.
  • 65
    Dash A,Dunn RL,Resh J,Wei JT,Montie JE,Sanda MG. Patient, surgeon, and treatment characteristics associated with homologous blood transfusion requirement during radical retropubic prostatectomy: multivariate nomogram to assist patient counseling. Urology 2004; 64: 117–22.
  • 66
    Van Poppel H,Collette L,Kirkali Z,Brausi M,Hoekstra W,Newling DW,Decoster M. Quality control of radical prostatectomy: a feasibility study. Eur J Cancer 2001; 37: 884–91.
  • 67
    Van Poppel H,Boulanger SF,Joniau S. Quality assurance issues in radical prostatectomy. Eur J Surg Oncol 2005; 31: 650–5.
  • 68
    Klein EA,Grass JA,Calabrese DA,Kay RA,Sargeant W,O'Hara JF. Maintaining quality of care and patient satisfaction with radical prostatectomy in the era of cost containment. Urology 1996; 48: 269–76.
  • 69
    Gardner TA,Bissonette EA,Petroni GR,McClain R,Sokoloff MH,Theodorescu D. Surgical and postoperative factors affecting length of hospital stay after radical prostatectomy. Cancer 2000; 89: 424–30.
    Direct Link:
  • 70
    Montorsi F,Briganti A,Salonia A,Rigatti P,Burnett AL. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 2004; 45: 123–33.
  • 71
    Meuleman EJ,Mulders PF. Erectile function after radical prostatectomy: a review. Eur Urol 2003; 43: 95–101.
  • 72
    Dubbelman YD,Dohle GR,Schroder FH. Sexual function before and after radical retropubic prostatectomy: a systematic review of prognostic indicators for a successful outcome. Eur Urol 2006; 50: 711–8.
  • 73
    Catalona WJ,Carvalhal GF,Mager DE,Smith DS. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 1999; 162: 433–8.
  • 74
    Salomon L,Levrel O,de la TA,Anastasiadis AG,Saint F,Zaki S,Vordos D,Cicco A,Olsson LE,Hoznek A,Chopin D,Abbou CC. Radical prostatectomy by the retropubic, perineal and laparoscopic approach: 12 years of experience in one center. Eur Urol 2002; 42: 104–10.
View Full Article (HTML) Get PDF (102K)